Donaldson's Q1 Earnings & Revenues Beat Estimates, Increase Y/Y

Donaldson reported fiscal Q1 FY26 adjusted EPS of $0.94 (vs. Zacks $0.93) and revenue of $935.4M (vs. $924M), up 3.9% year-over-year (2.6% cc). Mobile Solutions (64% of sales) generated $598.3M (+4.5%), Industrial Solutions $257.8M (+0.1%) and Life Sciences $79.3M (+13.1%); gross margin slipped 30bps to 35.2% amid tariff-related inflation while operating margin expanded 150bps to 16%. Cash flow remained strong with $125.4M from operations, free cash flow of $122M, $91.9M of buybacks and $34.7M of dividends; management guides FY26 adj. EPS $3.95–$4.11, sales +1–5%, capex $65–85M and FCF conversion 85–95% with plans to repurchase 2–3% of shares.

Analysis

Contrarian view: The market underestimates durability of Life Sciences and aftermarket — if FCF conversion sustains at >85% and buybacks hit upper band (3%), EPS could exceed the guide by 5–10% in 12 months, creating a potential mispricing. Conversely, consensus may be complacent about On‑Road exposure; a repeat quarterly decline >20% would materially cut FY26 upside. Historical parallel: industrial aftermarket leaders have outperformed during weak OEM cycles when FCF and buybacks accelerate (post‑2015 pattern). Unintended consequence: aggressive buybacks while debt creeps up increase leverage sensitivity to a 100–200bp rise in borrowing costs.

Key Decisions for Investors

• Establish a 2–3% long position in DCI within 2–6 weeks (scale in on pullbacks >3%) targeting +15% over 6–12 months; hard stop at -8% or if FY26 midpoint EPS falls below $3.80 or FCF conversion guidance drops under 80%.
• Implement a pair trade: long DCI (2%) vs short aerospace exposure via ETF XAR (1.5%) to hedge aerospace cyclicality; rebalance if DCI outperforms by >20% or XAR underperforms by >15% within 6 months.
• Buy a defined‑risk call spread on DCI with 9–15 month tenor (buy ~15% OTM call, sell ~30% OTM call) sized to risk 0.5–1.0% portfolio notional to capture guided EPS upside while capping premium.
• Increase weight (1–2%) in Flowserve (FLS) as a secondary play on industrial aftermarket demand and margin recovery; set target +20% in 9–12 months and stop at -10% if consensus EPS revisions turn negative.